Company / Shareholders' Equity
Medtronic Shareholders' Equity History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$48.0B
FY2025
5-year range
$48.0B / $52.6B
FY2021-FY2025
Trend
-4.4%
vs FY2024
Sector context
#6 of 161
Health Care
What the data says
Among 161 Health Care companies, Medtronic is in the top 4% for shareholders' equity. Shareholders' Equity has declined for 3 consecutive years, from $52.6B in FY2022 to $48.0B in FY2025.
Based on SEC 10-K filings.
$48.0B in FY2025 with a 5-year CAGR of -1.1%. Top quartile in the Health Care sector.
Declined from $51.5B to $48.0B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -3.0%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 161This company $48.0B Sector average $5.1B
▼
+848.4% above sector average
Key checks
Key Insights
- Medtronic's shareholders' equity has declined for 3 consecutive years.
- 5-year CAGR of -1.1%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 4.4% year-over-year.
- Ranks #6 out of 161 companies in the Health Care sector.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $48.0B | -4.4% |
| FY2024 | $50.2B | -2.5% |
| FY2023 | $51.5B | -2.0% |
| FY2022 | $52.6B | +2.2% |
| FY2021 | $51.4B | +1.4% |
| FY2020 | $50.7B | +1.3% |
| FY2019 | $50.1B | -1.2% |
| FY2018 | $50.7B | +1.0% |
| FY2017 | $50.2B | -3.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026